670nm red light therapy for eyes has attracted growing interest because researchers are investigating how deep red light may interact with the retina and the mitochondria inside retinal cells.

Unlike conventional lighting, photobiomodulation uses specific wavelengths and carefully controlled light exposure to investigate biological responses. In eye research, red and near-infrared wavelengths have been studied for their potential effects on retinal metabolism, mitochondrial function, oxidative stress, and visual performance.

But how could a simple wavelength of light affect cells inside the eye?

The answer begins with the retina's unusually high energy demands.

In this article, we explore the science behind 670nm red light for eyes, including mitochondria, cytochrome c oxidase, ATP production, retinal cells, and what human research has actually demonstrated.

---

What Is 670nm Red Light Therapy?

670nm refers to the wavelength of the light.

The number "670" means that the light has a wavelength of approximately 670 nanometers, placing it within the deep-red portion of visible light.

When low-intensity red or near-infrared light is used to investigate biological effects, the approach is commonly described as photobiomodulation, or PBM.

Photobiomodulation is being studied in many areas of biology and medicine. In ocular research, scientists have investigated red and near-infrared wavelengths in relation to retinal function and several eye conditions. Recent reviews describe mitochondrial activity as one of the major areas of interest.

It is important to remember that 670nm is a wavelength, not a treatment protocol.

Two devices can both emit 670nm light while delivering different irradiance, exposure times, energy doses, beam patterns, and distances.

Those differences can matter.

---

Why Would Light Affect the Retina?

At first glance, it may seem surprising that shining red light toward the eye could affect cellular metabolism.

The retina, however, is particularly well suited for studying light-based biological interactions.

The retina contains photoreceptors, including:

• rods

• cones

These cells continuously consume energy to maintain their electrical and biochemical functions.

The retina also has a very high density of mitochondria.

Mitochondria are responsible for producing much of the cell's usable energy in the form of adenosine triphosphate (ATP).

This makes mitochondrial function particularly important for retinal health and visual function.

Research from UCL has highlighted the unusually high metabolic demand of the retina and investigated whether long-wavelength red light could influence mitochondrial performance.

---

What Are Mitochondria?

Mitochondria are often called the "powerhouses" of cells.

Although this description is simplified, their central role is accurate: mitochondria help convert nutrients and oxygen into usable cellular energy.

One of the major products of this process is ATP.

ATP provides energy for many cellular activities, including processes required by retinal cells.

Photoreceptors have particularly demanding energy requirements because they continuously maintain ion gradients, renew cellular components, and participate in visual signaling.

This leads to an important research question:

Could improving mitochondrial efficiency influence retinal function?

This is one of the reasons researchers became interested in red and near-infrared light.

---

What Does 670nm Have to Do With Mitochondria?

One of the leading explanations for photobiomodulation involves mitochondrial components that interact with light.

A frequently studied target is cytochrome c oxidase, also known as complex IV.

Cytochrome c oxidase is part of the mitochondrial electron transport chain.

It plays an important role in the final stages of cellular respiration and contributes to the generation of the proton gradient used to produce ATP.

Reviews of photobiomodulation describe cytochrome c oxidase as one of the major proposed cellular targets of red and near-infrared light.

This does not mean that every photon of 670nm light simply "turns on" mitochondria.

The biological response is much more complicated.

Researchers continue to investigate exactly how wavelength, dose, cellular state, and other parameters influence the response.

---

How Could Light Influence Cytochrome c Oxidase?

One proposed mechanism involves photon absorption by components of cytochrome c oxidase.

Experimental research suggests that light absorption may influence the enzyme's activity and mitochondrial electron transport.

One hypothesis involves the interaction between cytochrome c oxidase and nitric oxide (NO). Under certain conditions, nitric oxide can interact with the enzyme and influence mitochondrial respiration.

Photobiomodulation research proposes that light exposure may alter this interaction, potentially facilitating electron transport and mitochondrial function.

Downstream effects may involve:

• mitochondrial membrane potential

• ATP production

• reactive oxygen species signaling

• calcium signaling

• cellular stress responses

These mechanisms have been discussed extensively in photobiomodulation research.

However, it is important to describe these as proposed mechanisms, rather than assuming that every mechanism has been conclusively established for 670nm light in the human retina.

---

What Is ATP and Why Does It Matter?

ATP stands for adenosine triphosphate.

It is one of the primary molecules cells use to store and transfer energy.

Think of ATP as a form of immediately usable cellular energy.

For retinal cells, energy is required for many processes involved in vision.

If mitochondrial function declines, cellular energy availability can also change.

This is particularly relevant to aging research.

UCL researchers have investigated the relationship between age-related mitochondrial changes and retinal function, including whether exposure to 670nm light could influence mitochondrial activity.

---

What Did UCL Researchers Find About 670nm and Mitochondria?

One important UCL study published in 2016 investigated the effect of 670nm light on mitochondrial redox activity in the retina.

Researchers used optical monitoring techniques to investigate changes in retinal mitochondrial respiration following exposure to 670nm light.

The study reported an increase in the redox state of retinal mitochondria following exposure.

This was important because it provided experimental evidence that 670nm light could be associated with measurable changes in mitochondrial activity in retinal tissue.

However, the study did not prove that every 670nm device produces the same effect in humans.

The exposure conditions and experimental setup matter.

---

670nm Red Light and the Retinal "Energy System"

The UCL research has sometimes been described using a simple analogy:

aging mitochondria are like a battery losing efficiency, and deep red light may help influence the energy-producing system.

This analogy can be useful for understanding the concept, but the biology is much more complicated.

Aging involves multiple processes, including:

• mitochondrial changes

• oxidative stress

• inflammation

• cellular damage

• changes in retinal metabolism

• changes in blood flow

• structural changes

Therefore, 670nm light should not be viewed as simply "recharging" the eye.

The more accurate scientific description is that researchers are investigating whether specific wavelengths of light can modulate cellular and mitochondrial processes.

---

What Happens After Mitochondrial Activation?

Mitochondria are only one part of the proposed mechanism.

Changes in mitochondrial activity can influence downstream cellular signaling.

Research into photobiomodulation has identified several possible pathways involving:

• ATP

• reactive oxygen species

• nitric oxide

• calcium signaling

• redox signaling

• gene expression

• inflammatory signaling

Some of these pathways may influence how cells respond to metabolic stress.

In retinal research, scientists are particularly interested in whether these effects could support photoreceptor function and cellular resilience.

Experimental studies involving 670nm light have reported mitochondrial and cellular effects in retinal models, including changes associated with oxidative stress and photoreceptor protection.

---

What About Oxidative Stress?

Oxidative stress occurs when reactive oxygen species and antioxidant defenses become imbalanced.

The retina is particularly vulnerable to oxidative stress because of its high metabolic activity and exposure to light.

Mitochondria themselves are involved in the production and regulation of reactive oxygen species.

Interestingly, photobiomodulation research does not simply suggest that red light "eliminates" reactive oxygen species.

Instead, controlled changes in reactive oxygen species may act as cellular signals.

This is sometimes described as redox signaling.

Research reviews suggest that photobiomodulation can produce dose-dependent changes in redox signaling and activate downstream cellular responses.

This is another reason why more light is not necessarily better.

---

Does 670nm Light Reach the Retina?

The eye has a unique optical structure that allows visible light to reach the retina.

Different wavelengths are absorbed, reflected, or transmitted differently by ocular tissues.

Red light has relatively long wavelengths compared with blue and green visible light.

This optical behavior is one reason researchers have investigated red and near-infrared wavelengths for ocular applications.

However, penetration and absorption depend on:

• wavelength

• tissue properties

• light intensity

• exposure geometry

• ocular structures

• individual characteristics

Therefore, simply knowing that a device emits 670nm does not tell us exactly how much energy reaches a particular retinal structure.

---

Why 670nm Instead of Blue Light?

Red and blue light behave differently biologically and optically.

Blue light has shorter wavelengths and higher photon energy.

Red light has longer wavelengths and lower photon energy.

For photobiomodulation research, red and near-infrared wavelengths are of particular interest because of their interaction with cellular and mitochondrial processes.

This does not mean that blue light is inherently "bad."

Blue light is an important component of normal vision and plays a role in circadian biology.

The research question is different:

Which wavelengths can produce useful biological responses under controlled exposure conditions?

That is why researchers study specific wavelengths rather than treating all visible light as equivalent.

---

What About 660nm?

660nm is another commonly studied red-light wavelength.

It is relatively close to 670nm, but the wavelengths are not identical.

Both belong to the red portion of the visible spectrum, and both have been investigated in photobiomodulation research.

However, evidence for 660nm should not automatically be described as evidence for 670nm.

This is particularly important when discussing eye-related research.

The UCL studies that attracted significant attention specifically used 670nm deep red light.

A later article in this series will examine 670nm vs. 660nm for the eyes in more detail.

---

What About 850nm Near-Infrared Light?

850nm is substantially different from 670nm.

850nm is in the near-infrared portion of the electromagnetic spectrum and is not visible to the human eye.

Both wavelengths have been investigated in photobiomodulation research, but they should not be treated as interchangeable.

Different wavelengths can interact differently with biological chromophores and tissues.

For example, recent mechanistic reviews discuss wavelength-dependent interactions involving mitochondrial components and different ocular targets.

A later article in this series will compare 670nm red light and near-infrared light for the eyes in more detail.

---

Can Mitochondrial Effects Improve Vision?

This is where it is important to distinguish mechanism from outcome.

Researchers can observe:

670nm exposure → measurable mitochondrial response

But that does not automatically establish:

670nm exposure → better eyesight

The second question requires human studies measuring actual visual outcomes.

This is why the UCL research is particularly important.

In addition to investigating mitochondrial mechanisms, researchers conducted human experiments measuring visual function.

---

What Did Human Research Show?

The UCL research provides some of the most frequently cited human evidence involving 670nm light and vision.

In one study, 24 adults aged 28–72 were exposed to 670nm deep red light for three minutes per day over two weeks.

The researchers tested rod and cone sensitivity before and after the intervention.

They reported improvements primarily among participants around 40 years and older, while younger participants showed little measurable effect.

A subsequent study investigated a single three-minute exposure.

In that study, participants received 670nm light in the morning between approximately 8 a.m. and 9 a.m.

The researchers reported an average 17% improvement in color contrast vision, with the effect lasting at least one week in the subset of participants tested at one week.

These findings are interesting because they connect a proposed cellular mechanism with a measurable visual outcome.

---

Why Might Age Matter?

The UCL researchers were particularly interested in aging.

The retina has a very high energy requirement, and mitochondrial function changes with age.

Their studies found stronger responses to 670nm exposure among older participants than younger participants.

One possible explanation is that the biological effect may be more noticeable when mitochondrial function has already declined.

This is an important concept in photobiomodulation research:

The response may depend on the initial biological state of the tissue.

Healthy young tissue and aging tissue may not respond identically to the same stimulus.

More research is needed to determine how age, retinal health, mitochondrial function, and light exposure interact.

---

Why Does Time of Day Matter?

The timing of exposure is another interesting part of the UCL research.

In the 2021 study, researchers compared morning and afternoon exposure.

The morning group received three minutes of 670nm light between 8 a.m. and 9 a.m.

The researchers reported an average improvement in color contrast vision.

A smaller group was subsequently tested following afternoon exposure between noon and 1 p.m., and the same improvement was not observed.

The researchers proposed that mitochondrial activity may follow daily biological rhythms.

This is an active area of research.

It does not mean that morning exposure is universally proven to be superior for every person or every 670nm device.

Instead, it suggests that time of day may be an important variable when studying red light and the retina.

---

Is the Mitochondrial Mechanism Proven?

Not completely.

There is substantial research supporting the idea that mitochondria are important targets of photobiomodulation.

However, the exact molecular mechanisms remain an active area of scientific investigation.

Different studies have proposed roles for:

• cytochrome c oxidase

• nitric oxide

• mitochondrial membrane potential

• ATP

• reactive oxygen species

• calcium signaling

• redox pathways

• cellular stress responses

Recent reviews emphasize that the biological mechanisms of photobiomodulation are complex and may vary according to wavelength, dose, tissue condition, and other parameters.

Therefore, it is more accurate to say:

Mitochondrial modulation is a leading research explanation for how red and near-infrared light may produce biological effects.

It is not accurate to reduce the entire process to a single mechanism.

---

Why Dose Matters

One of the most important concepts in photobiomodulation is dosimetry.

A wavelength alone does not define a treatment.

Researchers need to consider parameters such as:

• wavelength

• irradiance

• exposure duration

• energy density

• distance

• beam geometry

• modulation

• treatment frequency

For example, the 2021 UCL experiment used an LED device delivering approximately 8mW/cm², which was lower than the intensity used in the team's earlier work.

This illustrates why two devices both labeled "670nm" can produce different exposure conditions.

---

Is More Red Light Better?

Not necessarily.

Photobiomodulation is generally considered dose-dependent, meaning biological responses can vary with exposure parameters.

Increasing intensity or exposure duration does not automatically produce a proportionally larger biological response.

In some photobiomodulation research, excessively high doses can produce different or weaker responses than moderate doses.

This is why published protocols should not be interpreted as:

"If three minutes works, thirty minutes must work ten times better."

It does not work that way.

The correct exposure depends on the specific device, optical design, irradiance, and intended application.

---

670nm Red Light: What We Know and What We Don't

What research supports

Current research provides evidence that:

• 670nm light can interact with retinal tissue.

• Mitochondrial processes are an important area of investigation.

• Experimental studies have reported changes in retinal mitochondrial activity.

• Human studies have reported changes in specific measures of visual function.

• Age may influence the response.

• Time of day may influence the response.

• Dose and device parameters matter.

What remains uncertain

Research has not yet established that:

• every 670nm device produces the same biological effect

• every person experiences improved vision

• 670nm light treats all eye conditions

• longer exposure produces better results

• mitochondrial effects automatically produce clinical benefits

• 670nm light can replace conventional eye care

These distinctions are important when evaluating claims about red light and eye health.

---

670nm Red Light Therapy and Eye Health: The Bigger Picture

The scientific interest in 670nm red light comes from the connection between three areas:

1. Retinal energy demand

The retina requires substantial amounts of energy to maintain normal function.

2. Mitochondrial biology

Mitochondria generate much of the cellular energy needed by retinal cells.

3. Light-tissue interaction

Specific wavelengths of red and near-infrared light can interact with biological chromophores and cellular pathways.

This creates a research hypothesis:

Targeted red light may influence mitochondrial and cellular processes that are relevant to retinal function.

Human studies provide some encouraging evidence, but the field is still developing.

---

Frequently Asked Questions

How does 670nm red light work for the eyes?

Research suggests that red light may interact with mitochondrial components in retinal cells, potentially influencing cellular energy metabolism and signaling. Cytochrome c oxidase is one of the major proposed targets.

Does 670nm increase ATP?

Experimental research suggests that red and near-infrared photobiomodulation can influence mitochondrial energy metabolism and ATP-related processes. However, the exact response depends on wavelength, dose, tissue condition, and other factors.

Does 670nm reach the retina?

Visible red light can pass through the eye's optical structures and reach the retina. The amount reaching specific retinal tissues depends on wavelength and optical parameters.

Why is 670nm studied for vision?

670nm has been investigated because of its interaction with retinal tissue and mitochondrial processes. Human studies have also reported changes in specific measures of visual function.

Is 670nm better than 660nm?

Not necessarily. They are different wavelengths, and evidence from one wavelength should not automatically be transferred to the other. Direct comparisons are needed.

Is 670nm the same as 850nm?

No. 670nm is visible deep red light, while 850nm is near-infrared light. Both are studied in photobiomodulation, but they have different optical characteristics.

How long should 670nm red light be used?

There is no single universally established exposure time for all devices and purposes. Published studies use specific protocols, and exposure should follow the specifications of the device being used.

Does 670nm red light treat eye disease?

Research into 670nm and other red-light approaches for ocular conditions is ongoing. Evidence varies substantially by condition and protocol, and research findings should not be interpreted as proof that consumer devices treat or cure eye disease.

---

The Bottom Line

So, how does 670nm red light therapy for eyes work?

The leading scientific explanation begins with the retina's high energy requirements and its abundance of mitochondria.

Researchers are investigating whether 670nm light can interact with mitochondrial components such as cytochrome c oxidase and influence cellular energy metabolism, redox signaling, and other biological pathways.

Experimental studies have reported measurable mitochondrial effects, while human studies have reported changes in specific measures of visual function following controlled 670nm exposure.

But the complete biological pathway is more complicated than simply saying that red light "recharges" the mitochondria.

The most accurate way to describe the current science is:

670nm red light is being studied as a form of photobiomodulation that may influence mitochondrial and cellular processes in the retina. Early human research has produced encouraging findings for certain measures of visual function, but the optimal wavelength, dose, timing, and long-term effects continue to be investigated.

Understanding this mechanism provides the foundation for exploring more specific questions about 670nm red light and eye health—including retinal aging, macular health, eye strain, and age-related vision changes.